Skip to content

Feasibility of the Loop Brush EUS-FNA for Characterization of Pancreatic Cysts: Pilot Clinical Investigation

Feasibility of the Loop Brush EUS-FNA for Characterization of Pancreatic Cysts: Pilot Clinical Investigation

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07814326
Acronym
PCLoop-Pilot
Enrollment
8
Registered
2026-09-10
Start date
2026-10-01
Completion date
2028-03-01
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Brief summary

This investigation aims to demonstrate the feasibility of the lbFNA device for the first time in pancreatic cysts in humans. This study will be used as a base for further investigations on the safety and diagnostic accuracy of the lbFNA device.

Interventions

DEVICELoop Brush Fine Needle Aspiration

Loop Brush Fine Needle Aspiration (lbFNA) device is an endoscopy instrument used in this investigation for the puncture, brushing and aspiration of pancreatic cystic lesions prior to surgical removal of the pancreatic cystic lesion.

Sponsors

Urban Arnelo
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pancreatic cystic lesions that require surgical resection according to MDT conference * Assessed as fit for surgery * Age \>18 years * Given written informed consent to participate

Exclusion criteria

* Pregnancy * Cyst not accessible by lbFNA * Cyst not accessible for resection that includes the puncture canal for lbFNA * Cyst with calcified content * Inability to understand written or oral information, which hinders the ability to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Integrity of the lbFNA deviceFrom start of the lbFNA procedure until completion of the lbFNA procedure.Integrity of the device after withdrawing from the patient, evaluated according to a separate inspection protocol with special focus on the loop.

Countries

Sweden

Contacts

CONTACTUrban Arnelo
urban.arnelo@regionvasterbotten.se+46 90 785 0000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026